Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1996 Mar;103(3):376–383. doi: 10.1111/j.1365-2249.1996.tb08290.x

Therapeutic effects of estradiol benzoate on development of collagen-induced arthritis (CIA) in the Lewis rat are mediated via suppression of the humoral response against denatured collagen type II (CII)

Y WAKSMAN 1, I HOD 1, A FRIEDMAN 1
PMCID: PMC2200358  PMID: 8608634

Abstract

The effects of estradiol benzoate (EB) on the development of anti-CII antibodies and their pathogenic potential were studied during the progress of established CIA in the rat. CIA was induced in mature female Lewis rats by two subcutaneous inoculations containing bovine native CII (BCIIn), emulsified in Freund's incomplete adjuvant. Clinical arthritis fully developed by day 18 and then EB (1 mg/kg body wt per day, diluted in corn oil (CO)) was administered intramuscularly every second day thereafter. Antibodies binding four different CIIs (bovine or rat, either native or heat-denatured) were detected in sera and joint tissue extracts by means of solid-phase ELISA. Pharmacological doses of EB (>0·2 mg/kg body wt per day) caused significant remission of established CIA 5-7 days after treatment, and selectively suppressed the production of antibodies specific for denatured CII. To evaluate the arthritogenic potential of circulating anti-CIId IgG, transfer experiments were performed. IgG anti-CIIn, purified from EB-treated CIA rats, was not arthritogenic, whereas IgG anti-denatured (CIId), purified from CO-treated CIA rats, caused severe passive arthritis. Furthermore, pretreatment with rat CIId protected against subsequent induction of CIA, and this protection was associated with suppressed antibody production against CIId. Collectively, our results indicate that antibodies specific for CIId are involved in the pathogenesis of CIA, and that oestrogen-related remission of clinical arthritis may be caused by a selective suppression of antibodies produced against degraded/denatured CII.

Keywords: collagen-induced arthritis, sex hormones, anti-collagen antibodies

Full Text

The Full Text of this article is available as a PDF (737.8 KB).

References

  • 1.Grossman C. Possible underlying mechanisms of sexual dimorphism in the immne response. J Steroid Biochem. 1989;34:241–52. doi: 10.1016/0022-4731(89)90088-5. [DOI] [PubMed] [Google Scholar]
  • 2.Schuurs AHWM, Verheul HAM. Effect of gender and sex steroids on the immune response. J Steroid Biochem. 1990;35:157–72. doi: 10.1016/0022-4731(90)90270-3. [DOI] [PubMed] [Google Scholar]
  • 3.Nelson JL, Steinberg AD. Sex steroids, autoimmunity and autoimmune diseases. In: Berczi I, Kovack K, editors. Hormones and immunity. Lancaster: MTP press; 1987. pp. 93–119. [Google Scholar]
  • 4.Silver RM, Branch DW. Autoimmune diseases in pregnancy. Bailliers Clin Obstet Gynaecol. 1992;6:565–600. doi: 10.1016/s0950-3552(05)80011-2. [DOI] [PubMed] [Google Scholar]
  • 5.Vandenbroucke JP, Witteman JCM, Valkenburg HA, et al. Non-contraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. J Am Med Ass. 1986;255:1299–303. [PubMed] [Google Scholar]
  • 6.Hazes JMW, Dukmans BAC, Vandenbroucke JP, Cats A. Reduction of the risk of rheumatoid arthritis among women who take the oral contraceptives. Arthritis Rheum. 1990;33:173–9. doi: 10.1002/art.1780330204. [DOI] [PubMed] [Google Scholar]
  • 7.Bijlsma JW, Van den Brink HR. Estrogen and rheumatoid arthritis. AmJ Reprod Immunol. 1992;28:231–4. doi: 10.1111/j.1600-0897.1992.tb00800.x. [DOI] [PubMed] [Google Scholar]
  • 8.Hall GM, Daniels M, Huskisson EC, Spector TD. A randomized controlled trial on the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis. 1994;53:112–6. doi: 10.1136/ard.53.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Courtenay JS, Dalman MJ, Dayan AD, Martin A, Mosedale B. Immunization against heterologous type II collagen induced arthritis in mice. Nature. 1980;2843:666–8. doi: 10.1038/283666a0. [DOI] [PubMed] [Google Scholar]
  • 10.Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthrits. J Exp Med. 1977;146:857–68. doi: 10.1084/jem.146.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Stuart JM, Cremer MA, Townes AS, Kang AH. Type II collagen-induced arthritis in rats: passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982;155:1–16. doi: 10.1084/jem.155.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Trentham DE. Collagen arthritis as a relevant model for rheumatoid arthritis: evidence pro and con. Arthritis Rheum. 1982;25:911–6. doi: 10.1002/art.1780250801. [DOI] [PubMed] [Google Scholar]
  • 13.Ridge SC, Oronsky AL, Kerwar SS. Type II collagen-induced arthritis in rats. Methods Enzymol. 1988;162:355–60. doi: 10.1016/0076-6879(88)62090-8. [DOI] [PubMed] [Google Scholar]
  • 14.Holmdahl R, Jansson L, Anderson M. Female sex hormones suppress the development of collagen induced arthritis in mice. Arthritis Rheum. 1986;29:1501–9. doi: 10.1002/art.1780291212. [DOI] [PubMed] [Google Scholar]
  • 15.Larrson P, Holmdahl R. Oestrogen-induced suppression of collagen induced arthritis. II. Treatment of rats suppresses development of arthritis but does not effect anti-CII humoral response. Scand J Immunol. 1987;26:579–83. doi: 10.1111/j.1365-3083.1987.tb02292.x. [DOI] [PubMed] [Google Scholar]
  • 16.Larsson P, Go TJ, Klareskog L, Holmdahl R. Oestrogen-induced suppression of collagen induced arthritis in rats. Studies on the role of the thymus and peripheral CD8+ T lymphocytes. Scand J Immunol. 1989;30:741–7. doi: 10.1111/j.1365-3083.1989.tb02484.x. [DOI] [PubMed] [Google Scholar]
  • 17.Mattson R, Mattson A, Holmdahl R, Whyte A, Rook GAW. Maintained pregnancy levels of oestrogen afford complete protection from post partum exacerbation of collagen-induced arthritis. Clin Exp Immunol. 1991;85:41–47. doi: 10.1111/j.1365-2249.1991.tb05679.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Klareskog L, Holmdahl E, Larsson R, Wigzell H. Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol. 1983;51:117–25. [PMC free article] [PubMed] [Google Scholar]
  • 19.Brahn E, Trentham DE. Effect of anti-thymocye serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis. Cell Immunol. 1984;86:421–8. doi: 10.1016/0008-8749(84)90397-6. [DOI] [PubMed] [Google Scholar]
  • 20.Seki N, Sudo Y, Yoshioka T, et al. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell mediated immunity. J Immunol. 1988;140:1477–84. [PubMed] [Google Scholar]
  • 21.Takagishi H, Kaibara N, Hotokebuchi T, Arita C, Morinaya M, Arai K. Serum transfer of collagen induced arthritis in congenitally athymic nude rats. J Immunol. 1985;134:3864–7. [PubMed] [Google Scholar]
  • 22.Stuart JM, Tomoda K, Yoo TJ, Kang AV. Serum transfer of collagen induced arthritis. II. Identification and localization of autoantibodies to type II collagen in donor and recipient rats. Arthritis Rheum. 1983;26:1237–44. doi: 10.1002/art.1780261011. [DOI] [PubMed] [Google Scholar]
  • 23.Ofosu-Appiah WA, Morgan K, Holt PJL. Native type-II collagen induced arthritis in the rat. Studies of the humoral response to collagen at the cellular level. J Rheumatol. 1984;11:432–7. [PubMed] [Google Scholar]
  • 24.Michaeli D, Funberg HH. The incidence and antigenic specificity of antibodies directed against denatured human collagen in rheumatoid arthritis. Clin Immunol Immunopathol. 1974;2:153–9. doi: 10.1016/0090-1229(74)90035-x. [DOI] [PubMed] [Google Scholar]
  • 25.Rosenberg AM, Hunt DWC, Petty RE. Antibodies to native and denatured type II collagen in children with rheumatoid diseases. J Rheumatol. 1984;11:425–31. [PubMed] [Google Scholar]
  • 26.Rowley MJ, Williamson DJ, Mackay IR. Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis. Arthritis Rheum. 1987;30:1420–5. doi: 10.1002/art.1780301215. [DOI] [PubMed] [Google Scholar]
  • 27.Collins J, Morgan K, Clague RB, Brenchley PEC, Holt PJL. IgG subclass distribution of anti-native type II collagen and anti-denatured type II collagen antibodies in patients with rheumatoid arthritis. J Rheumatol. 1988;15:770–4. [PubMed] [Google Scholar]
  • 28.Ferriss J, Cooper S, Roessner K, Hochberg M. Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. J Rheumatol. 1990;17:880–4. [PubMed] [Google Scholar]
  • 29.Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with inter-leukin-1. Clin Invest. 1989;83:647–61. doi: 10.1172/JCI113929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Dodge GR, Pidoux I, Poole AR. The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study. Matrix. 1991;11:330–8. doi: 10.1016/s0934-8832(11)80204-0. [DOI] [PubMed] [Google Scholar]
  • 31.t' Hart BA, Bakker NPM, Jonker M, Bontrop RE. Resistance to collagen induced arthritis in rats and Rhesus monkeys after immunization with attenuated type II collagen. Eur J Immunol. 1993;23:1588–94. doi: 10.1002/eji.1830230729. [DOI] [PubMed] [Google Scholar]
  • 32.Miller EJ. Structural studies on cartilage employing limited cleavage and solubilization with pepsin. Biochem. 1972;11:4901–9. doi: 10.1021/bi00776a005. [DOI] [PubMed] [Google Scholar]
  • 33.Miller EJ, Rhodes RK. Preparation and characterization of the different types of collagen. Methods Enzymol. 1982;82:33–64. doi: 10.1016/0076-6879(82)82059-4. [DOI] [PubMed] [Google Scholar]
  • 34.Kaibara N, Hotokebuchi T, Takagishi K, Katsuki I. Paradoxical effects of cyclosporin A on collagen induced arthritis in rats. J Exp Med. 1983;158:2007–15. doi: 10.1084/jem.158.6.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.McKinney MM, Parkinson A. A simple, non-chromatographic procedure to purify imunoglobulins from serum and ascites fluid. J Immunol Methods. 1987;96:271–8. doi: 10.1016/0022-1759(87)90324-3. [DOI] [PubMed] [Google Scholar]
  • 36.Toivanen P, Maatta K, Suolanen R, Tykkylainen R. Effect of estrone and progesterone an adjuvant arthritis in rats. Med Pharmacol Exp. 1967;17:33–42. doi: 10.1159/000137052. [DOI] [PubMed] [Google Scholar]
  • 37.Mueller MN, Kappas A. Estradiol pharmacology. II. Suppression of experimental immune polyarthritis. Proc Soc Exp Biol Med. 1972;117:845–7. doi: 10.3181/00379727-117-29715. [DOI] [PubMed] [Google Scholar]
  • 38.Holmdahl R, Jansson L, Meyerson B, Klareskog L. Oestrogen induced suppression of collagen induced arthritis: I. Long term estradiol treatment of DBA/1 mice reduced severity and incidence of arthritis and decreased anti-collagen immune response. Clin Exp Immunol. 1987;70:372–8. [PMC free article] [PubMed] [Google Scholar]
  • 39.Okayasu I, Kong YM, Rose NR. Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clin Immunol Immunopathol. 1981;20:240–5. doi: 10.1016/0090-1229(81)90182-3. [DOI] [PubMed] [Google Scholar]
  • 40.Strigard K, Holmdahl R, Olsson T. Oestrogen treatment reduces disease duration of experimental allergic neuritis in rats and suppresses T cell response to myelin. Acta Neurol Scand. 1990;81:436–42. doi: 10.1111/j.1600-0404.1990.tb00991.x. [DOI] [PubMed] [Google Scholar]
  • 41.Carlsten H, Nilsson N, Jonsson R, Backman K, Holmdahl R, Tarkowsky A. Estrogen accelerates immune complex glomerulonephritis but ameliorates T-cell mediated vasculitis and sialadenitis in autoimmune MRL 1pr/1pr mice. Cell Immunol. 1992;144:190–202. doi: 10.1016/0008-8749(92)90236-i. [DOI] [PubMed] [Google Scholar]
  • 42.Carlsten H, Tarkowsky A. Histocompatibility complex gene production and exposure to oestrogens: two independent disease acceleration functions in murine lupus. Scand J Immunol. 1993;38:341–7. doi: 10.1111/j.1365-3083.1993.tb01736.x. [DOI] [PubMed] [Google Scholar]
  • 43.Ratkay LG, Zhang D, Tonzetich J, Levy JG, Waterfield JD. Evaluation of a model of post-partum arthritis and the role of oestrogen in prevention of MRL-1pr/1pr associated rheumatic conditions. Clin Exp Immunol. 1994;98:52–59. doi: 10.1111/j.1365-2249.1994.tb06606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Cremer MA, Terato K, Watson WC, Griffith MA, Townes AS, Kang AH. Collagen induced arthritis in rats. Examination of the epitope specificities of circulating and cartilage-bound antibodies produced by outbred and inbred rats using CNBr-derived peptides purified from heterologous and homologous CII. J Immunol. 1992;149:1045–53. [PubMed] [Google Scholar]
  • 45.Mo JA, Bona CA, Holmdahl R. Variable region gene selection of immunoglobulin G-expressing B cells with specificity for a defined epitope on type II collagen. Eur J Immunol. 1993;23:2503–10. doi: 10.1002/eji.1830231019. [DOI] [PubMed] [Google Scholar]
  • 46.Brand DD, Myers LK, Terato K, Whittington KB, Stuart JM, Kang AH, Rosloniec EF. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine α1(II)-CB11 in H-2q mice. J Immunol. 1994;152:3088–97. [PubMed] [Google Scholar]
  • 47.Friedman A, Al-Sabbagh A, Santos LMB, et al. Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens. In: Granstein RD, editor. Mechanisms of immune regulation. Basel: Karger; 1994. pp. 259–80. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES